Biotech & pharma
Controlling RNA in living cells
30 Apr 2016
Study uncovers memory molecules in plants
28 Apr 2016
New insights into enzymes to help reverse cancer, Alzheimer’s, Parkinson's
27 Apr 2016
New knowledge about the mechanism of specific protein complexes in the body could help in the development of better drugs for the treatment of diseases such as cancer, Parkinson's and Alzheimer's
Hydrogen-bonding pairing helps design better drugs to neutralize gut bacterial infections
28 Mar 2016
End-game for dengue as Indian scientists develop herbal remedy
09 Mar 2016
Indian scientists have developed an effective herbal medicine for the treatment of dengue, in what could be a potent remedy to the disease that affects millions of people within the country and across the world
Mutated gene safeguards against heart attacks
09 Mar 2016
Monsanto threatens pull-out over proposed royalty fee cut on GM seeds
05 Mar 2016
While Mahyco Monsanto Biotech (India), argues that the government has no role in determining trade fee, the government panel was clear in its view that the crop cost for cotton farmers has gone up after MMB substantially raised fees for sub-licensing BT seed technology
Study identifies genes linked to stroke risk
01 Mar 2016
Different organs have their own sexuality: study
24 Feb 2016
New nanotechnology detects biomarkers of cancer
19 Feb 2016
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
